Literature DB >> 9840612

Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease.

G R Somers1, F M Hammet, L Trute, M C Southey, D J Venter.   

Abstract

The human P2Y6 receptor is a member of the G-protein-coupled P2Y purinergic receptor family that responds to extracellular uridine diphosphate (UDP). In previous work, we cloned the human P2Y6 receptor from an activated T-cell library, and others have shown that it is expressed as a 1.9-kb transcript in several lymphoid tissues. This suggests a role for P2Y6 in T-cell function. However, the precise cellular expression pattern and regulation of P2Y6 in immune cells have not yet been established. In this study, we have examined the expression of P2Y6 in a range of tissues containing leukocytes by a combination of in situ hybridization (ISH), Northern blot analysis, and RT-PCR. Northern hybridization revealed that activated peripheral T cells show increased levels of P2Y6 mRNA. Furthermore, RT-PCR analysis of CD4+ and CD8+ subsets illustrated strong expression in both activated CD4+ and CD8+ T cells. Stimulation of resting and activated T cells with the P2Y6 ligand UDP caused a rise in the intracellular free calcium concentration in only the activated subset, indicating the presence of functional receptor. By ISH, P2Y6 expression was detected in the T cells of the thymic medulla and spleen, whereas no signal was detected in the bone marrow, fetal liver, or lymph nodes. T cells are thought to play an important role in the pathogenesis of inflammatory bowel disease (IBD), and because a recent finding has suggested a role for extracellular nucleotides in mediating colonic epithelial cell damage in IBD, we speculated that the P2Y6 nucleotide receptor may be expressed in the T cells infiltrating IBD. ISH results reveal that P2Y6 is highly expressed in the T cells infiltrating active IBD, whereas P2Y6 expression was absent from the T cells of unaffected bowel. These results demonstrate expression and regulation of P2Y6 expression in T cells, and suggest a role for P2Y6 in the pathogenesis of IBD-mediated intestinal damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840612

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  24 in total

1.  P2Y6 receptor mediates colonic NaCl secretion via differential activation of cAMP-mediated transport.

Authors:  Michael Köttgen; Thomas Löffler; Christoph Jacobi; Roland Nitschke; Hermann Pavenstädt; Rainer Schreiber; Sebastian Frische; Søren Nielsen; Jens Leipziger
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 2.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 4.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

5.  The purinergic G protein-coupled receptor 6 inhibits effector T cell activation in allergic pulmonary inflammation.

Authors:  Giorgio Giannattasio; Shin Ohta; Joshua R Boyce; Wei Xing; Barbara Balestrieri; Joshua A Boyce
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

6.  Functional expression of the P2Y14 receptor in murine T-lymphocytes.

Authors:  Michelle Scrivens; John M Dickenson
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

7.  Pharmacological characterization of uracil nucleotide-preferring P2Y receptors modulating intestinal motility: a study on mouse ileum.

Authors:  Maria Grazia Zizzo; Mariangela Mastropaolo; Jasmin Grählert; Flavia Mulè; Rosa Serio
Journal:  Purinergic Signal       Date:  2011-11-20       Impact factor: 3.765

8.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors.

Authors:  Liaman K Mamedova; Bhalchandra V Joshi; Zhan-Guo Gao; Ivar von Kügelgen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

9.  Nucleotidase cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralis.

Authors:  Kleoniki Gounaris
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate.

Authors:  Angela K Moss; Sulaiman R Hamarneh; Mussa M Rafat Mohamed; Sundaram Ramasamy; Halim Yammine; Palak Patel; Kanakaraju Kaliannan; Sayeda N Alam; Nur Muhammad; Omeed Moaven; Abeba Teshager; Nondita S Malo; Sonoko Narisawa; José Luis Millán; H Shaw Warren; Elizabeth Hohmann; Madhu S Malo; Richard A Hodin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.